COVID-19 UPDATE - FIND OUT HOW WE CAN HELP YOU Read News

Smart AI for early breast cancer detection and diagnosis

We focus on improving breast cancer survival rates by detecting cancers earlier and making treatment more effective and less invasive.

CE marked and FDA cleared 

READ OUR RESPONSE TO COVID-19 AND HOW TRANSPARA CAN HELP

Improving the way 2D and 3D mammograms are read

With the latest dedicated deep learning AI algorithms for breast cancer detection, Transpara provides radiologists with clinically proven decision support tools. Transpara is trained on over 1 million trusted mammograms and can help with daily workflow and workload. To find out more, please contact us

Transpara – the world’s first dedicated breast AI decision support solution for 2D and 3D mammography.

  • Commercially available right now. It is CE marked and FDA cleared
  • Multiple independent peer reviewed publications demonstrating improvement in accuracy and consistency 1
  • Proven multivendor compatibility 1

NOT ALL AI IS THE SAME – FIND OUT MORE ABOUT HOW TRANSPARA CAN HELP YOU


1. Published data held on file

Trained on over 1 million images

Use Transpara to:

Focus on early detection

Identify cancers earlier

Begin patient treatment earlier to improve survival rates

Improve mammography reading accuracy

With an improvement in accuracy and reduction in false positives, Transpara aims to minimize unnecessary treatments, patient distress and associated costs

Save time by Improving efficiency

Reduce waiting times for results

Transpara starts analysing mammograms immediately, providing objective information including level of suspicion to help the clinician with diagnosis

Rationalise radiologists’ ever-increasing workload by improving productivity

Radiologists face an ever-increasing workload so there is a need to work smarter whilst maintaining the highest quality levels when interpreting images. Transpara empowers radiologists to prioritise and focus on the most suspicious cases.

The Transpara Process

The Transpara Process
Client scan

Client scan

Client undergoes mammogram

Analyse scan

Analyse scan

Transpara analyses mammogram scan

Reading with Transpara

Reading with Transpara

Radiologist reads with support from Transpara, increasing confidence in decision

Result

Make more accurate and consistent decision

Who is Transpara for?

News

Article


Women’s Imaging Associates implements ScreenPoint Medical’s Transpara® to bring cutting edge 2D and 3D breast AI to benefit the women of Alabama

Women’s Imaging Associates and ScreenPoint Medical have announced today a strategic partnership to drive the earlier detection of breast cancer

Read more

Article


Summary of IWBI presentations using Transpara technology

As the leaders in evidence based AI decision support, we are proud that Transpara technology which is FDA cleared for

Read more

Article


Transpara in Dutch clinical practice featured in AD.nl

Read how Transpara is helping radiologists with cancer detection, confidence and reducing unnecessary biopsies at the Albert Schweitzer hospital in

Read more

Article


COVID-19 Update

According to various international societies, most breast screening and diagnostic exams are likely to be delayed due to the current

Read more
This is alt text

Article


Breaking news as Transpara™ 3D is cleared by FDA for clinical use in the USA

ScreenPoint Medical launches Transpara™ 1.6.0, the first breast AI solution for both 2D and 3D mammography in the USA. U.S.

Read more

Article


ECR 2020 postponed until July 15-19 – ScreenPoint Medical will be there

With the news that ECR will be postponed until July 15-19, 2020 due to the spreading corona virus epidemic, we

Read more